Socioeconomic factors increase mortality after lung cancer surgery
the ONA take:
According to a new study published online in the Journal of the American College of Surgeons, patients with limited education and low income have a greater risk of death within 30 days after undergoing surgery for lung cancer than those who are more educated and have more money.
For the study, researchers analyzed data from over 215,000 lung cancer operation admissions. Results showed that living in lower income households and in less-educated communities were independently associated with higher short-term postoperative mortality, in addition to other factors, including male gender, older age, late-stage cancer, multiple co-morbidities, and larger tumor size.
Specifically, those who resided in communities with a median household income of less than $30,000 had a 25% increased risk of dying after surgery within 30 days. Patients from less-educated communities had a 16% increased risk of death within 30 days compared with those from more educated communities.
"In order to get uniform superior outcomes for our patients, we need to identify the patients who are at risk for worse outcomes," said study co-author Felix G. Fernandez, MD, FACS, a lung surgeon and an assistant professor of surgery at Emory University School of Medicine. Atlanta. "This is the first step in describing where those disparities exist."
Patients with limited education and low income have a greater risk of death within 30 days after undergoing surgery for lung cancer.
- Neurotoxicity After CAR T-cell Therapy May Be Associated With Endothelial Activation
- Navigation Programs Most Effective in Increasing Follow-up Colonoscopy
- New Class of Clinical Trial Enhances Research on Cancer Care Delivery
- Specialized Interventions Reduce Aberrant Opioid Behaviors in Cancer Patients
- Nivolumab Provides Better Long-Term Efficacy Compared With Docetaxel in NSCLC
- Anticancer Properties of The Probiotic Kefir: A Review
- Navigating the Transition From Treatment to Breast Cancer Survivor
- Combining Radiation, Immunotherapy: An Emerging Challenge for Oncology Nursing
- Naldemedine Effective for Opioid-Induced Constipation in Cancer Pain
- Disruptions to Circadian Rhythm Linked to Prostate Cancer Surgery Regret
- Case Report of a KIT-mutated Melanoma Patient With an Excellent Response to Apatinib and Temozolomide Combination Therapy
- Novel Predictive Model More Effectively Identifies Risk for Lung Cancer
- Long-Term Eltrombopag Increases Platelet Counts, Decreases Bleeding in ITP
- Overall Survival Increase for Melanoma Brain Metastases
- Prophylactic Prochloperazine Ineffective for Opioid-induced Nausea/Vomiting in Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|